ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medication for Diabetes Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0Q17030
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Medication for Diabetes Market Research Report 2024
BUY CHAPTERS

Global Medication for Diabetes Market Research Report 2025

Code: QYRE-Auto-0Q17030
Report
September 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Tonghua Dongbao
Gan & Lee Pharmaceuticals
Shandong Lukang Pharmaceutical
Otsuka Pharmaceutical
East China Pharmaceutical
BeiLu Pharmaceutical
Furen Pharmaceutical
Astrazeneca plc
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol–Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer Inc
Astellas Pharma
Daiichi Sankyo
Biocon Ltd.
Glenmark
Bayer
Takeda
Sun Pharma
Gan & Lee Pharmaceuticals
Johnson & Johnson

Medication for Diabetes Market

The global market for Medication for Diabetes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Medication for diabetes is a broad term that refers to any drug or treatment that helps people with diabetes manage their blood sugar levels. Blood sugar levels are affected by the amount of glucose (sugar) in the blood and the action of insulin, a hormone that helps cells use glucose for energy. People with diabetes either do not produce enough insulin, or their cells do not respond well to insulin, or both. This causes high blood sugar levels, which can lead to serious complications such as heart disease, kidney failure, nerve damage, and vision loss. Medication for diabetes aims to lower blood sugar levels to a healthy range and prevent or delay these complications.
North American market for Medication for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Medication for Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Medication for Diabetes in Type 1 Diabetes Treatment is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Medication for Diabetes include Tonghua Dongbao, Gan & Lee Pharmaceuticals, Shandong Lukang Pharmaceutical, Otsuka Pharmaceutical, East China Pharmaceutical, Beilu Pharmaceutical, Furen Pharmaceutical, AstraZeneca, Novartis, Novo Nordisk, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medication for Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medication for Diabetes.
The Medication for Diabetes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medication for Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medication for Diabetes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Medication for Diabetes Market Report

Report Metric Details
Report Name Medication for Diabetes Market
Segment by Type
  • Biguanides
  • Sulfonylureas
  • Thiazolidinedione
  • α-Glucosidase Inhibitors
  • DPP-4 Inhibitors
  • GLP-1 Receptor Agonists
  • SGLT-2 Inhibitors
  • Insulins
Segment by Application
  • Type 1 Diabetes Treatment
  • Type 2 Diabetes Treatment
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Tonghua Dongbao, Gan & Lee Pharmaceuticals, Shandong Lukang Pharmaceutical, Otsuka Pharmaceutical, East China Pharmaceutical, Beilu Pharmaceutical, Furen Pharmaceutical, AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi, Pfizer, Astellas Pharma, Daiichi Sankyo, Biocon, Glenmark, Bayer AG, Takeda, Sun pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Medication for Diabetes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Medication for Diabetes Market report?

Ans: The main players in the Medication for Diabetes Market are Tonghua Dongbao, Gan & Lee Pharmaceuticals, Shandong Lukang Pharmaceutical, Otsuka Pharmaceutical, East China Pharmaceutical, Beilu Pharmaceutical, Furen Pharmaceutical, AstraZeneca, Novartis, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi, Pfizer, Astellas Pharma, Daiichi Sankyo, Biocon, Glenmark, Bayer AG, Takeda, Sun pharma

What are the Application segmentation covered in the Medication for Diabetes Market report?

Ans: The Applications covered in the Medication for Diabetes Market report are Type 1 Diabetes Treatment, Type 2 Diabetes Treatment

What are the Type segmentation covered in the Medication for Diabetes Market report?

Ans: The Types covered in the Medication for Diabetes Market report are Biguanides, Sulfonylureas, Thiazolidinedione, α-Glucosidase Inhibitors, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT-2 Inhibitors, Insulins

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication for Diabetes Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biguanides
1.2.3 Sulfonylureas
1.2.4 Thiazolidinedione
1.2.5 α-Glucosidase Inhibitors
1.2.6 DPP-4 Inhibitors
1.2.7 GLP-1 Receptor Agonists
1.2.8 SGLT-2 Inhibitors
1.2.9 Insulins
1.3 Market by Application
1.3.1 Global Medication for Diabetes Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Type 1 Diabetes Treatment
1.3.3 Type 2 Diabetes Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medication for Diabetes Market Perspective (2020-2031)
2.2 Global Medication for Diabetes Growth Trends by Region
2.2.1 Global Medication for Diabetes Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Medication for Diabetes Historic Market Size by Region (2020-2025)
2.2.3 Medication for Diabetes Forecasted Market Size by Region (2026-2031)
2.3 Medication for Diabetes Market Dynamics
2.3.1 Medication for Diabetes Industry Trends
2.3.2 Medication for Diabetes Market Drivers
2.3.3 Medication for Diabetes Market Challenges
2.3.4 Medication for Diabetes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medication for Diabetes Players by Revenue
3.1.1 Global Top Medication for Diabetes Players by Revenue (2020-2025)
3.1.2 Global Medication for Diabetes Revenue Market Share by Players (2020-2025)
3.2 Global Medication for Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Medication for Diabetes Revenue
3.4 Global Medication for Diabetes Market Concentration Ratio
3.4.1 Global Medication for Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication for Diabetes Revenue in 2024
3.5 Global Key Players of Medication for Diabetes Head office and Area Served
3.6 Global Key Players of Medication for Diabetes, Product and Application
3.7 Global Key Players of Medication for Diabetes, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication for Diabetes Breakdown Data by Type
4.1 Global Medication for Diabetes Historic Market Size by Type (2020-2025)
4.2 Global Medication for Diabetes Forecasted Market Size by Type (2026-2031)
5 Medication for Diabetes Breakdown Data by Application
5.1 Global Medication for Diabetes Historic Market Size by Application (2020-2025)
5.2 Global Medication for Diabetes Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Medication for Diabetes Market Size (2020-2031)
6.2 North America Medication for Diabetes Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Medication for Diabetes Market Size by Country (2020-2025)
6.4 North America Medication for Diabetes Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medication for Diabetes Market Size (2020-2031)
7.2 Europe Medication for Diabetes Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Medication for Diabetes Market Size by Country (2020-2025)
7.4 Europe Medication for Diabetes Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medication for Diabetes Market Size (2020-2031)
8.2 Asia-Pacific Medication for Diabetes Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Medication for Diabetes Market Size by Region (2020-2025)
8.4 Asia-Pacific Medication for Diabetes Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medication for Diabetes Market Size (2020-2031)
9.2 Latin America Medication for Diabetes Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Medication for Diabetes Market Size by Country (2020-2025)
9.4 Latin America Medication for Diabetes Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medication for Diabetes Market Size (2020-2031)
10.2 Middle East & Africa Medication for Diabetes Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Medication for Diabetes Market Size by Country (2020-2025)
10.4 Middle East & Africa Medication for Diabetes Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Tonghua Dongbao
11.1.1 Tonghua Dongbao Company Details
11.1.2 Tonghua Dongbao Business Overview
11.1.3 Tonghua Dongbao Medication for Diabetes Introduction
11.1.4 Tonghua Dongbao Revenue in Medication for Diabetes Business (2020-2025)
11.1.5 Tonghua Dongbao Recent Development
11.2 Gan & Lee Pharmaceuticals
11.2.1 Gan & Lee Pharmaceuticals Company Details
11.2.2 Gan & Lee Pharmaceuticals Business Overview
11.2.3 Gan & Lee Pharmaceuticals Medication for Diabetes Introduction
11.2.4 Gan & Lee Pharmaceuticals Revenue in Medication for Diabetes Business (2020-2025)
11.2.5 Gan & Lee Pharmaceuticals Recent Development
11.3 Shandong Lukang Pharmaceutical
11.3.1 Shandong Lukang Pharmaceutical Company Details
11.3.2 Shandong Lukang Pharmaceutical Business Overview
11.3.3 Shandong Lukang Pharmaceutical Medication for Diabetes Introduction
11.3.4 Shandong Lukang Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025)
11.3.5 Shandong Lukang Pharmaceutical Recent Development
11.4 Otsuka Pharmaceutical
11.4.1 Otsuka Pharmaceutical Company Details
11.4.2 Otsuka Pharmaceutical Business Overview
11.4.3 Otsuka Pharmaceutical Medication for Diabetes Introduction
11.4.4 Otsuka Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025)
11.4.5 Otsuka Pharmaceutical Recent Development
11.5 East China Pharmaceutical
11.5.1 East China Pharmaceutical Company Details
11.5.2 East China Pharmaceutical Business Overview
11.5.3 East China Pharmaceutical Medication for Diabetes Introduction
11.5.4 East China Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025)
11.5.5 East China Pharmaceutical Recent Development
11.6 Beilu Pharmaceutical
11.6.1 Beilu Pharmaceutical Company Details
11.6.2 Beilu Pharmaceutical Business Overview
11.6.3 Beilu Pharmaceutical Medication for Diabetes Introduction
11.6.4 Beilu Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025)
11.6.5 Beilu Pharmaceutical Recent Development
11.7 Furen Pharmaceutical
11.7.1 Furen Pharmaceutical Company Details
11.7.2 Furen Pharmaceutical Business Overview
11.7.3 Furen Pharmaceutical Medication for Diabetes Introduction
11.7.4 Furen Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025)
11.7.5 Furen Pharmaceutical Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Medication for Diabetes Introduction
11.8.4 AstraZeneca Revenue in Medication for Diabetes Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Medication for Diabetes Introduction
11.9.4 Novartis Revenue in Medication for Diabetes Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Details
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk Medication for Diabetes Introduction
11.10.4 Novo Nordisk Revenue in Medication for Diabetes Business (2020-2025)
11.10.5 Novo Nordisk Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Medication for Diabetes Introduction
11.11.4 Johnson & Johnson Revenue in Medication for Diabetes Business (2020-2025)
11.11.5 Johnson & Johnson Recent Development
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Details
11.12.2 Boehringer Ingelheim Business Overview
11.12.3 Boehringer Ingelheim Medication for Diabetes Introduction
11.12.4 Boehringer Ingelheim Revenue in Medication for Diabetes Business (2020-2025)
11.12.5 Boehringer Ingelheim Recent Development
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Details
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Medication for Diabetes Introduction
11.13.4 Bristol-Myers Squibb Revenue in Medication for Diabetes Business (2020-2025)
11.13.5 Bristol-Myers Squibb Recent Development
11.14 Eli Lilly
11.14.1 Eli Lilly Company Details
11.14.2 Eli Lilly Business Overview
11.14.3 Eli Lilly Medication for Diabetes Introduction
11.14.4 Eli Lilly Revenue in Medication for Diabetes Business (2020-2025)
11.14.5 Eli Lilly Recent Development
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Medication for Diabetes Introduction
11.15.4 Merck Revenue in Medication for Diabetes Business (2020-2025)
11.15.5 Merck Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Medication for Diabetes Introduction
11.16.4 Sanofi Revenue in Medication for Diabetes Business (2020-2025)
11.16.5 Sanofi Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Details
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Medication for Diabetes Introduction
11.17.4 Pfizer Revenue in Medication for Diabetes Business (2020-2025)
11.17.5 Pfizer Recent Development
11.18 Astellas Pharma
11.18.1 Astellas Pharma Company Details
11.18.2 Astellas Pharma Business Overview
11.18.3 Astellas Pharma Medication for Diabetes Introduction
11.18.4 Astellas Pharma Revenue in Medication for Diabetes Business (2020-2025)
11.18.5 Astellas Pharma Recent Development
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Details
11.19.2 Daiichi Sankyo Business Overview
11.19.3 Daiichi Sankyo Medication for Diabetes Introduction
11.19.4 Daiichi Sankyo Revenue in Medication for Diabetes Business (2020-2025)
11.19.5 Daiichi Sankyo Recent Development
11.20 Biocon
11.20.1 Biocon Company Details
11.20.2 Biocon Business Overview
11.20.3 Biocon Medication for Diabetes Introduction
11.20.4 Biocon Revenue in Medication for Diabetes Business (2020-2025)
11.20.5 Biocon Recent Development
11.21 Glenmark
11.21.1 Glenmark Company Details
11.21.2 Glenmark Business Overview
11.21.3 Glenmark Medication for Diabetes Introduction
11.21.4 Glenmark Revenue in Medication for Diabetes Business (2020-2025)
11.21.5 Glenmark Recent Development
11.22 Bayer AG
11.22.1 Bayer AG Company Details
11.22.2 Bayer AG Business Overview
11.22.3 Bayer AG Medication for Diabetes Introduction
11.22.4 Bayer AG Revenue in Medication for Diabetes Business (2020-2025)
11.22.5 Bayer AG Recent Development
11.23 Takeda
11.23.1 Takeda Company Details
11.23.2 Takeda Business Overview
11.23.3 Takeda Medication for Diabetes Introduction
11.23.4 Takeda Revenue in Medication for Diabetes Business (2020-2025)
11.23.5 Takeda Recent Development
11.24 Sun pharma
11.24.1 Sun pharma Company Details
11.24.2 Sun pharma Business Overview
11.24.3 Sun pharma Medication for Diabetes Introduction
11.24.4 Sun pharma Revenue in Medication for Diabetes Business (2020-2025)
11.24.5 Sun pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Tonghua Dongbao
Gan & Lee Pharmaceuticals
Shandong Lukang Pharmaceutical
Otsuka Pharmaceutical
East China Pharmaceutical
BeiLu Pharmaceutical
Furen Pharmaceutical
Astrazeneca plc
Novartis
Novo Nordisk
Johnson & Johnson
Boehringer Ingelheim
Bristol–Myers Squibb
Eli Lilly
Merck
Sanofi
Pfizer Inc
Astellas Pharma
Daiichi Sankyo
Biocon Ltd.
Glenmark
Bayer
Takeda
Sun Pharma
Gan & Lee Pharmaceuticals
Johnson & Johnson
List of Tables
 Table 1. Global Medication for Diabetes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Biguanides
 Table 3. Key Players of Sulfonylureas
 Table 4. Key Players of Thiazolidinedione
 Table 5. Key Players of α-Glucosidase Inhibitors
 Table 6. Key Players of DPP-4 Inhibitors
 Table 7. Key Players of GLP-1 Receptor Agonists
 Table 8. Key Players of SGLT-2 Inhibitors
 Table 9. Global Medication for Diabetes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Medication for Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Medication for Diabetes Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Medication for Diabetes Market Share by Region (2020-2025)
 Table 13. Global Medication for Diabetes Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Medication for Diabetes Market Share by Region (2026-2031)
 Table 15. Medication for Diabetes Market Trends
 Table 16. Medication for Diabetes Market Drivers
 Table 17. Medication for Diabetes Market Challenges
 Table 18. Medication for Diabetes Market Restraints
 Table 19. Global Medication for Diabetes Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Medication for Diabetes Market Share by Players (2020-2025)
 Table 21. Global Top Medication for Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Diabetes as of 2024)
 Table 22. Ranking of Global Top Medication for Diabetes Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Medication for Diabetes Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Medication for Diabetes, Headquarters and Area Served
 Table 25. Global Key Players of Medication for Diabetes, Product and Application
 Table 26. Global Key Players of Medication for Diabetes, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Medication for Diabetes Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Medication for Diabetes Revenue Market Share by Type (2020-2025)
 Table 30. Global Medication for Diabetes Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Medication for Diabetes Revenue Market Share by Type (2026-2031)
 Table 32. Global Medication for Diabetes Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Medication for Diabetes Revenue Market Share by Application (2020-2025)
 Table 34. Global Medication for Diabetes Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Medication for Diabetes Revenue Market Share by Application (2026-2031)
 Table 36. North America Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Medication for Diabetes Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Medication for Diabetes Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Medication for Diabetes Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Medication for Diabetes Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Medication for Diabetes Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Medication for Diabetes Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Medication for Diabetes Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Medication for Diabetes Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Medication for Diabetes Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Medication for Diabetes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Medication for Diabetes Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Medication for Diabetes Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Tonghua Dongbao Company Details
 Table 52. Tonghua Dongbao Business Overview
 Table 53. Tonghua Dongbao Medication for Diabetes Product
 Table 54. Tonghua Dongbao Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 55. Tonghua Dongbao Recent Development
 Table 56. Gan & Lee Pharmaceuticals Company Details
 Table 57. Gan & Lee Pharmaceuticals Business Overview
 Table 58. Gan & Lee Pharmaceuticals Medication for Diabetes Product
 Table 59. Gan & Lee Pharmaceuticals Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 60. Gan & Lee Pharmaceuticals Recent Development
 Table 61. Shandong Lukang Pharmaceutical Company Details
 Table 62. Shandong Lukang Pharmaceutical Business Overview
 Table 63. Shandong Lukang Pharmaceutical Medication for Diabetes Product
 Table 64. Shandong Lukang Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 65. Shandong Lukang Pharmaceutical Recent Development
 Table 66. Otsuka Pharmaceutical Company Details
 Table 67. Otsuka Pharmaceutical Business Overview
 Table 68. Otsuka Pharmaceutical Medication for Diabetes Product
 Table 69. Otsuka Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 70. Otsuka Pharmaceutical Recent Development
 Table 71. East China Pharmaceutical Company Details
 Table 72. East China Pharmaceutical Business Overview
 Table 73. East China Pharmaceutical Medication for Diabetes Product
 Table 74. East China Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 75. East China Pharmaceutical Recent Development
 Table 76. Beilu Pharmaceutical Company Details
 Table 77. Beilu Pharmaceutical Business Overview
 Table 78. Beilu Pharmaceutical Medication for Diabetes Product
 Table 79. Beilu Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 80. Beilu Pharmaceutical Recent Development
 Table 81. Furen Pharmaceutical Company Details
 Table 82. Furen Pharmaceutical Business Overview
 Table 83. Furen Pharmaceutical Medication for Diabetes Product
 Table 84. Furen Pharmaceutical Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 85. Furen Pharmaceutical Recent Development
 Table 86. AstraZeneca Company Details
 Table 87. AstraZeneca Business Overview
 Table 88. AstraZeneca Medication for Diabetes Product
 Table 89. AstraZeneca Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 90. AstraZeneca Recent Development
 Table 91. Novartis Company Details
 Table 92. Novartis Business Overview
 Table 93. Novartis Medication for Diabetes Product
 Table 94. Novartis Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 95. Novartis Recent Development
 Table 96. Novo Nordisk Company Details
 Table 97. Novo Nordisk Business Overview
 Table 98. Novo Nordisk Medication for Diabetes Product
 Table 99. Novo Nordisk Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 100. Novo Nordisk Recent Development
 Table 101. Johnson & Johnson Company Details
 Table 102. Johnson & Johnson Business Overview
 Table 103. Johnson & Johnson Medication for Diabetes Product
 Table 104. Johnson & Johnson Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 105. Johnson & Johnson Recent Development
 Table 106. Boehringer Ingelheim Company Details
 Table 107. Boehringer Ingelheim Business Overview
 Table 108. Boehringer Ingelheim Medication for Diabetes Product
 Table 109. Boehringer Ingelheim Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 110. Boehringer Ingelheim Recent Development
 Table 111. Bristol-Myers Squibb Company Details
 Table 112. Bristol-Myers Squibb Business Overview
 Table 113. Bristol-Myers Squibb Medication for Diabetes Product
 Table 114. Bristol-Myers Squibb Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 115. Bristol-Myers Squibb Recent Development
 Table 116. Eli Lilly Company Details
 Table 117. Eli Lilly Business Overview
 Table 118. Eli Lilly Medication for Diabetes Product
 Table 119. Eli Lilly Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 120. Eli Lilly Recent Development
 Table 121. Merck Company Details
 Table 122. Merck Business Overview
 Table 123. Merck Medication for Diabetes Product
 Table 124. Merck Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 125. Merck Recent Development
 Table 126. Sanofi Company Details
 Table 127. Sanofi Business Overview
 Table 128. Sanofi Medication for Diabetes Product
 Table 129. Sanofi Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 130. Sanofi Recent Development
 Table 131. Pfizer Company Details
 Table 132. Pfizer Business Overview
 Table 133. Pfizer Medication for Diabetes Product
 Table 134. Pfizer Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 135. Pfizer Recent Development
 Table 136. Astellas Pharma Company Details
 Table 137. Astellas Pharma Business Overview
 Table 138. Astellas Pharma Medication for Diabetes Product
 Table 139. Astellas Pharma Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 140. Astellas Pharma Recent Development
 Table 141. Daiichi Sankyo Company Details
 Table 142. Daiichi Sankyo Business Overview
 Table 143. Daiichi Sankyo Medication for Diabetes Product
 Table 144. Daiichi Sankyo Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 145. Daiichi Sankyo Recent Development
 Table 146. Biocon Company Details
 Table 147. Biocon Business Overview
 Table 148. Biocon Medication for Diabetes Product
 Table 149. Biocon Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 150. Biocon Recent Development
 Table 151. Glenmark Company Details
 Table 152. Glenmark Business Overview
 Table 153. Glenmark Medication for Diabetes Product
 Table 154. Glenmark Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 155. Glenmark Recent Development
 Table 156. Bayer AG Company Details
 Table 157. Bayer AG Business Overview
 Table 158. Bayer AG Medication for Diabetes Product
 Table 159. Bayer AG Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 160. Bayer AG Recent Development
 Table 161. Takeda Company Details
 Table 162. Takeda Business Overview
 Table 163. Takeda Medication for Diabetes Product
 Table 164. Takeda Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 165. Takeda Recent Development
 Table 166. Sun pharma Company Details
 Table 167. Sun pharma Business Overview
 Table 168. Sun pharma Medication for Diabetes Product
 Table 169. Sun pharma Revenue in Medication for Diabetes Business (2020-2025) & (US$ Million)
 Table 170. Sun pharma Recent Development
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. Authors List of This Report


List of Figures
 Figure 1. Medication for Diabetes Picture
 Figure 2. Global Medication for Diabetes Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medication for Diabetes Market Share by Type: 2024 VS 2031
 Figure 4. Biguanides Features
 Figure 5. Sulfonylureas Features
 Figure 6. Thiazolidinedione Features
 Figure 7. α-Glucosidase Inhibitors Features
 Figure 8. DPP-4 Inhibitors Features
 Figure 9. GLP-1 Receptor Agonists Features
 Figure 10. SGLT-2 Inhibitors Features
 Figure 11. Insulins Features
 Figure 12. Global Medication for Diabetes Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Medication for Diabetes Market Share by Application: 2024 VS 2031
 Figure 14. Type 1 Diabetes Treatment Case Studies
 Figure 15. Type 2 Diabetes Treatment Case Studies
 Figure 16. Medication for Diabetes Report Years Considered
 Figure 17. Global Medication for Diabetes Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Medication for Diabetes Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Medication for Diabetes Market Share by Region: 2024 VS 2031
 Figure 20. Global Medication for Diabetes Market Share by Players in 2024
 Figure 21. Global Top Medication for Diabetes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication for Diabetes as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Medication for Diabetes Revenue in 2024
 Figure 23. North America Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Medication for Diabetes Market Share by Country (2020-2031)
 Figure 25. United States Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Medication for Diabetes Market Share by Country (2020-2031)
 Figure 29. Germany Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Medication for Diabetes Market Share by Region (2020-2031)
 Figure 37. China Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Medication for Diabetes Market Share by Country (2020-2031)
 Figure 45. Mexico Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Medication for Diabetes Market Share by Country (2020-2031)
 Figure 49. Turkey Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Medication for Diabetes Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Tonghua Dongbao Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 53. Gan & Lee Pharmaceuticals Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 54. Shandong Lukang Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 55. Otsuka Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 56. East China Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 57. Beilu Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 58. Furen Pharmaceutical Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 59. AstraZeneca Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 60. Novartis Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 61. Novo Nordisk Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 62. Johnson & Johnson Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 63. Boehringer Ingelheim Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 65. Eli Lilly Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 66. Merck Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 67. Sanofi Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 68. Pfizer Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 69. Astellas Pharma Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 70. Daiichi Sankyo Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 71. Biocon Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 72. Glenmark Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 73. Bayer AG Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 74. Takeda Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 75. Sun pharma Revenue Growth Rate in Medication for Diabetes Business (2020-2025)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Type 2 Diabetes Medications Market Research Report 2024
Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Type 2 Diabetes Medicines Market Research Report 2024
Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Drugs for Diabetes Market Research Report 2024
Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Care Drugs Market Insights Forecast to 2030
Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drugs For Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypoglycemic Drugs Market Insights Forecast to 2030
Global Type 2 Diabetes Mellitus Treatment Market Research Report 2024
Global Insulin Drugs for Diabetes Market Research Report 2024
Injectable Drugs For Type 2 Diabete Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Needle Free Diabetes Care Market Research Report 2024
Global Oral Antidiabetic Drugs Market Insights Forecast to 2030
Global Hormonal Therapy for Type 2 Diabetes Market Research Report 2024
Oral Hypoglycemic Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Foot Medicine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions